GSK considers splitting up
GlaxoSmithKline is reportedly considering whether to split its business into a consumer health spin-off and standalone pharmaceutical and vaccines group.
Read More
Tag: MMV
GSK, MMV submit malaria drug in the US
GlaxoSmithKline and the Medicines for Malaria Venture are seeking permission to market single-dose tafenoquine in the US to prevent relapse of Plasmodium vivax malaria.
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
